641 related articles for article (PubMed ID: 15070917)
1. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
[TBL] [Abstract][Full Text] [Related]
2. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
Ibáñez L; Valls C; Cabré S; De Zegher F
J Clin Endocrinol Metab; 2004 Sep; 89(9):4716-20. PubMed ID: 15356085
[TBL] [Abstract][Full Text] [Related]
3. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.
Ibáñez L; De Zegher F
J Clin Endocrinol Metab; 2003 Oct; 88(10):4720-4. PubMed ID: 14557446
[TBL] [Abstract][Full Text] [Related]
4. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2005 Jan; 90(1):39-43. PubMed ID: 15483105
[TBL] [Abstract][Full Text] [Related]
5. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
Ibáñez L; De Zegher F
Hum Reprod; 2004 Aug; 19(8):1725-7. PubMed ID: 15229206
[TBL] [Abstract][Full Text] [Related]
6. Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.
Ibáñez L; Diaz M; Sebastiani G; Sánchez-Infantes D; Salvador C; Lopez-Bermejo A; de Zegher F
J Clin Endocrinol Metab; 2011 Nov; 96(11):3361-6. PubMed ID: 21865363
[TBL] [Abstract][Full Text] [Related]
7. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
Ibáñez L; de Zegher F
Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
[TBL] [Abstract][Full Text] [Related]
8. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
[TBL] [Abstract][Full Text] [Related]
9. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
Ibáñez L; Valls C; Ferrer A; Ong K; Dunger DB; De Zegher F
J Clin Endocrinol Metab; 2002 Jun; 87(6):2870-4. PubMed ID: 12050266
[TBL] [Abstract][Full Text] [Related]
10. Divergent effects of ethinylestradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess.
Ibáñez L; Díaz M; López-Bermejo A; de Zegher F
Gynecol Endocrinol; 2011 Mar; 27(3):197-8. PubMed ID: 20528210
[TBL] [Abstract][Full Text] [Related]
11. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
[TBL] [Abstract][Full Text] [Related]
12. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.
Ibáñez L; López-Bermejo A; del Rio L; Enríquez G; Valls C; de Zegher F
J Clin Endocrinol Metab; 2007 May; 92(5):1710-4. PubMed ID: 17299064
[TBL] [Abstract][Full Text] [Related]
13. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
Ibáñez L; de Zegher F
Fertil Steril; 2006 Jul; 86 Suppl 1():S24-5. PubMed ID: 16798281
[TBL] [Abstract][Full Text] [Related]
14. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.
Ibáñez L; Jaramillo AM; Ferrer A; de Zegher F
Hum Reprod; 2005 Sep; 20(9):2457-62. PubMed ID: 15905296
[TBL] [Abstract][Full Text] [Related]
15. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.
Ibáñez L; Valls C; Marcos MV; Ong K; Dunger DB; De Zegher F
J Clin Endocrinol Metab; 2004 Sep; 89(9):4331-7. PubMed ID: 15356029
[TBL] [Abstract][Full Text] [Related]
16. Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.
Ibáñez L; Díaz M; Sebastiani G; Marcos MV; López-Bermejo A; de Zegher F
J Clin Endocrinol Metab; 2013 May; 98(5):E902-7. PubMed ID: 23547047
[TBL] [Abstract][Full Text] [Related]
17. Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome.
Ibáñez L; de Zegher F
Hum Reprod; 2003 Jan; 18(1):57-60. PubMed ID: 12525441
[TBL] [Abstract][Full Text] [Related]
18. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
[TBL] [Abstract][Full Text] [Related]
19. Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue.
Díaz M; Chacón MR; López-Bermejo A; Maymó-Masip E; Salvador C; Vendrell J; de Zegher F; Ibáñez L
J Clin Endocrinol Metab; 2012 Oct; 97(10):3630-8. PubMed ID: 22791755
[TBL] [Abstract][Full Text] [Related]
20. Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial.
Moro F; Morciano A; Tropea A; Sagnella F; Palla C; Scarinci E; Ciardulli A; Martinez D; Familiari A; Liuzzo G; Tritarelli A; Cosentino N; Niccoli G; Crea F; Lanzone A; Apa R
Reprod Sci; 2013 Dec; 20(12):1508-17. PubMed ID: 23690338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
